Sector News

Transaction positions Jaguar to advance the Laminar program and its differentiated approach to left atrial appendage closure for patients with non-valvular atrial fibrillation SANTA ROSA, Calif., Sept. 11, 2026 /PRNewswire/ -- Jaguar LAA, Inc.

This article first appeared on GuruFocus. Novo Nordisk A/S (NVO, Financials), the Danish drugmaker behind Wegovy and Ozempic, is facing a problem that may arrive well before its patent cliff.

Blazing high-grade issuance for a holiday-shortened week back from Labor Day — a historically explosive period for pent-up dealmaking after summer lulls — totaled $57 billion Tuesday and Wednesday alone across 30 offerings, raising the possibility of a fourth straight monthly record. The totals in June ($184 billion),...

This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) shares fell more than 2% Friday after Morgan Stanley lowered its rating on the drugmaker, citing longer-term risks tied to semaglutide and pressure from potential generic competition.

When considering dividend-paying stocks, those with a history of increasing payouts are prime candidates, reflecting their commitment to increasingly rewarding shareholders. And when it comes to a consistent history of increased payouts, look no further than the Dividend Aristocrats.

Wall Street’s major averages closed higher on Friday after the latest consumer inflation report came in largely in line with expectations. The blue-chip Dow (DJI [https://seekingalpha.com/symbol/DJI]) finished +0.9%, the benchmark S&P 500 (SP500...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week.

Eli Lilly and Company's LLY portfolio is overwhelmingly driven by its popular GLP-1 medicines, Mounjaro and Zepbound. However, the company's broader strategy is becoming increasingly clear — leverage the substantial cash flow generated by its cardiometabolic franchise to fund strategic acquisitions, expand its...